Australia · Company Research
CSL Was Once the ASX’s Safe Growth Story. Now It Has to Prove It Again
For years, CSL Limited (ASX:CSL) enjoyed the rarest status on the ASX: a growth company that also felt defensive. Plasma, vaccines, rare diseases, global scale, high barriers to…